Sleep apnea impacts 21 million Americans and can lead to high blood pressure, heart disease and stroke. While the continuous positive airway pressure (CPAP) device is the gold-standard treatment, more than 40 percent of sleep apnea patients refuse to use it.
Companies are now marketing an implant that delivers stimulation to open key airway muscles during sleep. Controlled by a remote or wearable patch, the technology acts like a pacemaker, helping synchronize air intake with the action of the tongue, using a breathing sensor and a battery-powered stimulation lead.
In this video, learn why neuromodulation to treat sleep apnea is No. 2 on Cleveland